8-K
filed September 14, 2023, 7:59 PM ET
ticker VNOV
CIK 0001699709
leadership
confidence high
sentiment neutral
materiality 0.70
VitaNova Life Sciences Corp (VNOV): M&A transaction — Yijia Group founder/CEO Xianchang Ma dies; heir gets 86.3% control; new CEO appointed
VitaNova Life Sciences Corp
- Founder and sole director Xianchang Ma passed away on August 3, 2023.
- On Sept 12, 2023, heir Caihong Qu acquired 5,066,250 shares (86.3% of outstanding) at $0 consideration, gaining control.
- Effective Sept 13, 2023, board comprises Qiuping Lu and Ruiming Zhou; Lu appointed CEO, President, and CFO.
- Ms. Lu previously served as CEO and CFO of China Herb Group Holdings from 2014 to 2019.
- Mr. Zhou has been a director at Shandong Tengjunxiang Biotechnology Co. since June 2017.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Xianchang Ma departed as Chief Executive Officer, President, Chief Financial Officer and Director at VitaNova Life Sciences Corp.
- Action
- passed away
- Role
- Chief Executive Officer, President, Chief Financial Officer and Director
Exact text from the filing
Mr. Xianchang Ma, previously the Chief Executive Officer, President, Chief Financial Officer and Director of the Company, passed away on August 3, 2023.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Qiuping Lu was appointed as Chief Executive Officer, President, Chief Financial Officer at VitaNova Life Sciences Corp.
- Action
- appointed
- Role
- Chief Executive Officer, President, Chief Financial Officer
Exact text from the filing
On September 13, 2023, the Board resolved to appoint Ms. Qiuping Lu as the Chief Executive Officer, President, Chief Financial Officer of the Company.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Ruiming Zhou was appointed as Director at VitaNova Life Sciences Corp.
- Action
- inducted
- Role
- Director
Exact text from the filing
On September 13, 2023, the majority shareholder inducted Ms. Qiuping Lu, and Mr. Ruiming Zhou to the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Qiuping Lu was appointed as Director at VitaNova Life Sciences Corp.
- Action
- inducted
- Role
- Director
Exact text from the filing
On September 13, 2023, the majority shareholder inducted Ms. Qiuping Lu, and Mr. Ruiming Zhou to the Board.
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.7
VitaNova Life Sciences Corp underwent a change of control involving Ms. Caihong Qu for $0 (closed 2023-09-12).
- Action
- change of control
- Counterparty
- Ms. Caihong Qu
- Consideration
- $0
- Closing
- 2023-09-12
Exact text from the filing
Ms. Caihong Qu, Mr. Xianchang Ma's sole heir, was allocated 5,066,250 shares of the Company's common stock at a consideration of $0.
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.